Oppenheimer analyst Jay Olson reiterated an Outperform rating and $380.00 price target on Amgen (NASDAQ: AMGN).The analyst commented, "The FDA ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE